Portal:IEM/CoveredPathways
From WikiPathways
Chapter ed. 5 | Title | Links WP | Chapter ed. 4 | Status | Diseases: x from ch. ed. 4 (+y) from other ch. |
---|---|---|---|---|---|
13 | Disorders of pyrimidine and purine metabolism | WP4225 and WP4224 | 41 | Approved (ed.5) | |
14 | Disorders of Nucleotide Metabolism | ||||
15 | Creatine disorders | WP5190 | 32 | Approved | |
16 | Disorders of glutathione metabolism | WP4518 | 42 | Approved | |
17 | Disorders of ammonia detoxification | WP4595 | 4 | Approved | |
18 | Disorders of amino acid transport | WP5029 | 6 | Approved | |
19 | Disorders of monoamine metabolism | WP4220 | 31 | Approved (ed.5) | 6, non missing |
20 | Disorders of phenylalanine and tetrahydrobiopterin metabolism | WP4156 | 1 | Approved (ed.5) | 8 (+2), non missing |
21 | Disorders of tyrosine metabolism | WP4506 | 2 | Approved (ed.5) | 5, non missing |
22 | Disorders of sulfur amino acid and sulfide metabolism | WP4292 | 3 | Approved | 7, non missing |
23 | Disorders of branched-chain amino acid metabolism | WP4686 | 7 | Approved | |
24 | Disorders of Beta and Gamma Amino Acids | Fig.24.2: WP4157 | 5 (Fig.5.3) | Approved (ed.5) | 2, non missing |
26 | Disorders of glycine metabolism | Fig.5.1:WP5028, Fig.5.4: WP5026 | 5 | In Progress | |
26 | Disorders of glycine metabolism | Fig.5.2: WP4688 | 5 | Approved | |
27 | Disorders of Lipoic Acid and Iron-Sulphur Protein Metabolism | ||||
28 | Disorders of cobalamin metabolism | WP4271 | 13 | Approved | |
29 | Disorders of folate metabolism | WP4259 and WP4288 | 10 | Approved | 9 (+3), non missing |
30 | Disorders of biotin metabolism | WP5031 | 14 | Approved | |
31 | Disorders of thiamine metabolism | WP4297 | 15 | Approved | |
32 | Disorders of riboflavin metabolism | WP5037 | 16 | Approved | |
33 | Disorders of Niacin, NAD, and Pantothenate Metabolism | ||||
34 | Vitamin B6 -Dependent and Responsive Disorders | WP4228 | 11 | Approved (ed.5) | 5, non missing |
35 | Disorders of molybdenum metabolism | WP4507 and WP4504 | 12 | Approved | |
36 | Disorders of copper , zinc and selenium metabolism | WP5189 | 39 | Approved | |
37 | Iron metabolism disorder | WP5172 | 40 | Approved | |
38 | Disorders of Manganese Metabolism | ||||
39 | Disorders of carbohydrate and glucose transport | Fig.18.3:WP5173, Fig.18.4: WP5178 | 18 | Approved | |
40 | Disorders of Pentose Phosphate Pathway and Polyol Metabolism | ||||
41 | Disorders Congenital Hyperinsulinism | ||||
42 | Disorders of pyruvate and Krebs cycle metabolism | WP4236 | 20 | Approved | |
43 | Disorders of Mitochondrial Carriers | ||||
44 | Isolated Mitochondrial Complex Deficiencies | ||||
45 | Disorders of Replication, Transcription and Translation of Mitochondrial DNA | ||||
46 | Disorders of Mitochondrial Homeostatis, Dynamics, Protein Import, and Quality Control | ||||
47 | Primary CoQ10 deficiencies | WP5037 | 16 | Approved | |
48 | Disorders of carnitine, fatty acid and fatty aldehyde metabolism | WP5123 | 17 | In Progress | |
49 | Disorders of Glycerol Metabolism | ||||
50 | Disorders of ketone body metabolism | Fig.23.1 and 23.2:WP5175, Fig.23.3: WP5195 | 23 | Approved | |
51 | Disorders of Complex Lipids | ||||
52 | Disorders of eicosanoid metabolism (including leukotrienes) | WP5171 | 38 | Approved | |
53 | Disorders of lipoprotein metabolism | WP4522 | 43 | Approved | |
54 | Cholesterol synthesis disorders | WP5193 | 36 | Approved | |
55 | Disorders of steroid metabolism | WP4523 and WP4524 | 37 | Approved | |
56 | Disorders of Bile acid synthesis (and biliary transport) | WP5176 | 34 | Approved | |
57 | Disorders of Heme metabolism | WP5169 | 33 | Approved | |
58 | Inherited Disorders of Bilirubin Metabolite | ||||
59 | Disorders of Autophagy | ||||
60 | Lysosomal storage disorders | WP4153 | 25 | Approved (ed.5) | 8, 8 unconnected |
61 | The Neuronal Ceroid Lipofuscinoses | no pathway diagram | |||
62 | Mucolipidoses, Multiple Sulfatase Deficiency, and Cathepsin K and C Deficiency | ||||
63 | Oligosaccharidoses and Sialic Acid Disorders | ||||
64 | The Mucopolysaccharidoses | ||||
65 | Disorders of oxalate metabolism | WP5166 | 28 | Approved | |
66 | Congenital disorders of N-linked and O-linked glycosylation | WP4521 | 30 | Approved | |
67 | Disorders of Oxalate Metabolism | ||||
68 | Congenital Disorders of Glycosylation | ||||
69 | Cerebral organic acidurias | WP4519 and WP5030 | 8 & 9 | Approved | |
70 | 3-Methylglutaconic Acidurias | ||||
- | Disorders of phosphoinositide metabolism | WP4971 | NA | Approved | |
- | Oxysterols derived from cholesterol | WP4545 | NA | Approved | |
- | Mitochondrial oxidative phosphorylation | 22 | In Progress |
Information on Pathway Curation:
This Table provides an overview of which chapters have been covered by WikiPathways. Approved pathways are coloured blue; pathways which still need work (however are a part of the database) are coloured orange.
Tip:
Click on the arrows behind the Table headers to sort this table based on Chapter number (edition 4 and 5 available), title, WikiPathways reference and Curation Status.
Pathway Visualisations
View all digitized Pathways from the Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases by Blau et al. (see it on Scholia.)
How to add a pathway to the portal
The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact Denise Slenter.